Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.10 is 51% below its 3-year average of -0.73, near the low end of its 3-year range (-1.29–-0.34).
0.92% below its 12-month average of -1.09.
Reported quarterly EPS; no daily interpolation. Q1 FY2026 (2026-07-31): 0.00.
EARNINGS PER SHARE (EPS)
-1.10
EARNINGS PER SHARE (EPS) AVG TTM
-1.09
EARNINGS PER SHARE (EPS) AVG 3Y
-0.73
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.92%
CURRENT VS 3Y AVG
-50.68%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MiniMed Group, Inc. Common Stock
Market Cap
$5.52B
Earnings Per Share (EPS)
-1.10
TTM Avg
-1.09
3Y Avg
-0.73
5Y Avg
N/A
Market Cap
$5.53B
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.11
3Y Avg
0.01
5Y Avg
0.03
Market Cap
$5.61B
Earnings Per Share (EPS)
-2.70
TTM Avg
-1.75
3Y Avg
-1.29
5Y Avg
-1.09
Market Cap
$5.32B
Earnings Per Share (EPS)
-0.58
TTM Avg
1.92
3Y Avg
-3.08
5Y Avg
-4.40
Market Cap
$5.78B
Earnings Per Share (EPS)
-4.19
TTM Avg
-3.83
3Y Avg
-4.76
5Y Avg
-4.52
Market Cap
$5.79B
Earnings Per Share (EPS)
-0.70
TTM Avg
-1.19
3Y Avg
-1.69
5Y Avg
-1.81
Market Cap
$5.21B
Earnings Per Share (EPS)
-4.76
TTM Avg
-5.40
3Y Avg
-5.28
5Y Avg
-3.57
Market Cap
$5.21B
Earnings Per Share (EPS)
-0.49
TTM Avg
-2.79
3Y Avg
-3.24
5Y Avg
-3.33
Market Cap
$5.20B
Earnings Per Share (EPS)
0.57
TTM Avg
0.22
3Y Avg
-0.05
5Y Avg
0.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.52B | -1.10 | -1.09 | -0.73 | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | -0.27 | -0.11 | 0.01 | 0.03 |
| CG Oncology Inc. (CGON)vs › | $5.61B | -2.70 | -1.75 | -1.29 | -1.09 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | -0.58 | 1.92 | -3.08 | -4.40 |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | -4.19 | -3.83 | -4.76 | -4.52 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -0.70 | -1.19 | -1.69 | -1.81 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -4.76 | -5.40 | -5.28 | -3.57 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -0.49 | -2.79 | -3.24 | -3.33 |
| Sotera Health Company (SHC)vs › | $5.20B | 0.57 | 0.22 | -0.05 | 0.01 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 0.85 | 1.12 | 0.90 | 0.76 |
Trailing EPS (TTM)
$-1.10
Forward EPS (Est.)
$0.67
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-04-24 | -1.29 |
| 2025-04-30 | -0.89 |
| 2024-04-30 | -0.40 |
| 2023-04-30 | -0.34 |
